Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 2, 2011, Pages 121-131

  Wigal, Sharon B ^a   Wigal, Tim ^a   Schuck, Sabrina ^a   Brams, Matthew ^b   Williamson, David ^c   Armstrong, Robert B ^c   Starr, H Lynn ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; OSMOTIC RELEASE ORAL SYSTEM METHYLPHENIDATE; PLACEBO; UNCLASSIFIED DRUG;

ACADEMIC ACHIEVEMENT; ANXIETY; APPETITE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIGIT SPAN SUBTEST OF THE WECHSLER INTELLIGENCE SCALE FOR CHILDREN; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RELEASE; DYNAMIC INDICATORS OF BASIC EARLY IITERACY SKILLS; ETHNICITY; FEMALE; FEVER; FINGER WINDOWS SUBTEST OF THE WIDE RANGE ASSESSMENT OF MEMORY AND LEARNING; GRAY SILENT READING TEST; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOSE CONGESTION; OUTCOME ASSESSMENT; PERMANENT PRODUCT MEASURE OF PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCREENING; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SOCIAL BEHAVIOR; SWANSON, KOTKIN, AGLER, M-FLYNN, AND PELHAM SCALES OF ATTENTION AND DEPORTMENT; TEST OF HANDWRITING SKILLS, REVISED; TEST OF VARIABLES OF ATTENTION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UPPER ABDOMINAL PAIN; WORKING MEMORY;

ADMINISTRATION, ORAL; ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; COGNITION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHOOLS; TREATMENT OUTCOME;

EID: 79955156393     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0047     Document Type: Article

References (53)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
2. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ: Modifiers of long-term school outcomes for children with attentiondeficit/ hyperactivity disorder: Does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr 28:274-287, 2007.
3. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ: Long-term stimulant medication treatment of attention- deficit/hyperactivity disorder: Results from a population-based study. J Dev Behav Pediatr 27:1-10, 2006.
4. Baren M, Swanson J: How not to diagnose ADHD. Contemp Pediatr 13:53-64, 1996.
5. Bedard AC, Jain U, Hogg-Johnson S, Tannock R: Effects of methylphenidate on working memory components: Influence of measurement. J Child Psychol Psychiatry 48:872-880, 2007.
6. Bedard AC, Tannock R: Anxiety, methylphenidate response, and workingmemory in childrenwithADHD. JAttenDisord 11:546-557, 2008.
7. Breslau J: The impact of early behavior disturbances on academic achievement in high school. Pediatrics 123:1472-1476, 2009.
8. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R: Characterizing cognition in ADHD: Beyond executive dysfunction. Trends Cogn Sci 10:117-123, 2006.
9. DeShazo-Barry T, Lyman RD, Klinger LG: Academic underachievement and attention/deficit hyperactivity disorder: the negative impact of symptom severity on school performance. J Sch Psychol 40:259-283, 2002.
10. DuPaul G, Power T, Anastopolous A, Reid R: ADHD Rating Scale- IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Publications; 1998.
11. Dykman RA, Ackerman PT: Attention deficit disorder and specific reading disability: Separate but often overlapping disorders. J Learn Disabil 24:96-103, 1991.
12. Elia J, Welsh PA, Gulotta CS, Rapoport JL: Classroom academic performance: Improvement with both methylphenidate and dextroamphetamine in ADHD boys. J Child Psychol Psychiatry 34:785-804, 1993.
13. Evans SW, Pehlham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, Altenderfer L, Baron-Myak C: Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9:163-175, 2001.
14. Faraone S, Biederman J, Monuteaux MC, Doyle A, Seidman L: A psychometric measure of learning disability predicts educational failure four years later in boys with attention-deficit/hyperactivity disorder. J Atten Disord 4:220-230, 2001.
15. Flake RA, Lorch EP, Milich R: The effects of thematic importance on story recall among children with attention deficit hyperactivity disorder and comparison children. J Abnorm Child Psychol 35:43-53, 2007.
16. Fletcher JM, Lyon GR, Fuchs LS, Barnes MA: Learning Disabilities: From Identification to Intervention. New York: Guilford Publications; 2007.
17. Forbes GB: Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol 54:461-476, 1998.
18. Gathercole SE, Pickering SJ, Knight C, Stegmann Z: Working memory skills and educational attainment: Evidence from national curriculum assessments at 7 and 14 years of age. Appl Cogn Psychol 18:1-16, 2004.
19. Ghelani K, Sidhu R, Jain U, Tannock R: Reading comprehension and reading related abilities in adolescents with reading disabilitiesand attention-deficit/hyperactivity disorder. Dyslexia 10:364-384, 2004.
20. Good RH, Kaminski RA (eds): Dynamics Indicators of Basic Early Literacy Skills, 6th edition. Eugene, OR: Institute for the Development of Educational Achievement; 2002.
21. Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, Blum C, Greenfield B, Etcovitch J, Fleiss K, Pollack S: Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43:812-819, 2004.
22. Huang YS, Chao CC, Wu YY, Chen YY, Chen CK: Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Psychiatry Clin Neurosci 61:219-225, 2007.
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
24. Leark RA, Greenberg LM, Kindschi CL, Dupuy TR, Hughes SJ: TOVA Professional Manual: Test of Variables of Attention Continuous Performance Test. Los Alamitos, CA: The TOVA Company; 2007.
25. Loe IM, Feldman HM: Academic and educational outcomes of children with ADHD. J Pediatr Psychol 32:643-654, 2007.
26. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R: A metaanalysis of working memory impairments in children with attention- deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44:377-384, 2005.
27. McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S: Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry 42:673-683, 2003.
28. McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E: A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord 9:476-485, 2006.
29. Milone M: Test of Handwriting Skills, Revised Manual. Novato, CA: Academic Therapy Publications; 2007.
30. National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services: Report of the National Reading Panel: Teaching Children to Read (00-4769). Washington, DC: US Government Printing Office; 2000.
31. Pastor PN, Reuben CA: Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital Health Stat 10:1-14, 2008.
32. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107:E105, 2001.
33. Racine MB, Majnemer A, Shevell M, Snider L: Handwriting performance in children with attention deficit hyperactivity disorder (ADHD). J Child Neurol 23:399-406, 2008.
34. Schatz A, Ballantyne A, Trauner D: Sensitivity and specificity of a computerized test of attention in the diagnosis of attention-deficit/ hyperactivity disorder. Assessment 8:357-365, 2001.
35. Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S: Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 123:1273-1279, 2009.
36. Semrud-Clikeman M, Biederman J, Sprich-Buckminster S, Lehman B, Faraone S, Norman D: Comorbidity between ADHD and learning disability: A review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry 31:439-448, 1992.
37. Spencer TJ, Biederman J, Mick E: Attention-deficit/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. J Ped Psychol 32:631-642, 2007.
38. Steele M, Jensen PS, Quinn DM: Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clin Ther 28:1892-1908, 2006.
39. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S: Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder. Arch Gen Psychiatr 60:204-211, 2003.
40. Swanson JM, Agler D, Fineberg E: UCI laboratory school protocol for PK/PD studies. In: Ritalin: Theory and Practice, 2nd edition. Edited by L. Greenhill, B. Osman. New Rochelle, NY: Mary Ann Liebert, Inc.; 2000; pp. 405-430.
41. Swanson JM, Lerner M, Wigal T, Steinhoff K, Greenhill L, Posner K, Freid J, Wigal S: The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. J Atten Disord 6:S73-S88, 2002.
42. Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group: A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113:e206-e216, 2004.
43. The MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
44. Vance AL, Maruff P, Barnett R: Attention deficit hyperactivity disorder combined type: Better executive function performance with longer-term psychostimulant medication. Aust NZ J Psychiatry 37:570-576, 2003.
45. Wagner RK, Torgesen JK, Rashotte CA: Comprehensive Test of Phonological Processing. Austin, TX: Pro-ed Publishing; 1999.
46. Wechsler D: Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: The Psychological Corporation; 1999.
47. Wechsler D: Wechsler Individual Achievement Test, 2nd edition. San Antonio, TX: The Psychological Corporation; 2001.
48. Wiederholt J, Bryant B: GORT 4: Gray Oral Reading Tests Examiner's Manual. Austin, TX: Pro-ed Publishing; 2001.
49. Wigal S, Gupta S, Guinta D, Swanson JM: Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull 34:47-53, 1998.
50. Wigal S, Sanchez D, DeCory HH, D'Imperio J, Swanson J: Selection of the optimal dose ratio for a controlled-delivery formulation of methylphenidate. J Appl Res 3:46-63, 2003.
51. Wigal SB, Wigal TL: The laboratory school protocol: Its origin, use, and new applications. J Atten Disord 10:92-111, 2006.
52. Wigal SB, Kollins S, Childress A, Squires L: A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health 9:17-31, 2009.
53. Wigal SB, Wigal TL, Kollins SH: Advances in methylphenidate drug delivery systems for ADHD therapy. Adv ADHD 1:4-7, 2006.